Gemtuzumab ozogamicin can reduce minimal residual disease in patients with childhood acute myeloid leukemia
2011 ◽
Vol 11
(9)
◽
pp. 1391-1401
◽
2004 ◽
Vol 79
(3)
◽
pp. 243-249
◽
Keyword(s):